KLAR — Klaria Pharma Holding AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK125.45m
- SEK123.53m
- SEK2.25m
Annual cashflow statement for Klaria Pharma Holding AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -48.7 | -50.1 | -55 | -31.8 | -31.2 |
| Depreciation | |||||
| Non-Cash Items | — | 13.3 | -0.106 | 0.041 | 4.76 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.01 | 1.06 | -5.68 | 11.7 | 3.33 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -35.3 | -24.8 | -49.7 | -9.06 | -11.9 |
| Capital Expenditures | -0.033 | 0 | -0.042 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 13.1 | 0 | 0 | 0 | 0 |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 13.1 | 0 | -0.042 | 0 | 0 |
| Financing Cash Flow Items | 0 | -1.04 | -0.678 | -0.342 | -1.36 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 50.6 | 19 | 41.1 | -6.46 | 11.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 28.3 | -5.76 | -8.73 | -15.5 | -0.649 |